REQUEST A DEMO
Total
USD $0.00
Search more companies

Mecsek-Drog Kft. (Hungary)

Main Activities: Coffee and Tea Manufacturing
Full name: MECSEK-DROG Termelo es Kereskedelmi Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Mecsek-Drog Kft. is based in Hungary. The head office is in Pecsvarad. It operates in the Coffee and Tea Manufacturing sector. It was incorporated on February 11, 1991. It currently has a total number of 22 (2024) employees. From the latest financial highlights, Mecsek-Drog Kft. reported a net sales revenue increase of 3.48% in 2023. During that time, Mecsek-Drog Kft.’s total assets grew by 14.55%. In 2023, Mecsek-Drog Kft.’s net profit margin increased by 1.69%.

Headquarters
Erzsebeti utca 18.
Pecsvarad; Baranya; Postal Code: 7720

Contact Details: Purchase the Mecsek-Drog Kft. report to view the information.

Website: http://www.mecsektea.hu

Basic Information
Total Employees:
Purchase the Mecsek-Drog Kft. report to view the information.
Outstanding Shares:
Purchase the Mecsek-Drog Kft. report to view the information.
Registered Capital:
Purchase the Mecsek-Drog Kft. report to view the information.
Financial Auditors:
Purchase the Mecsek-Drog Kft. report to view the information.
Incorporation Date:
February 11, 1991
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Mecsek Reformhaz Kft.
Company Performance
Financial values in the chart are available after Mecsek-Drog Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
3.48%
Total operating revenue
5.1%
Operating profit (EBIT)
25.78%
EBITDA
47.01%
Net Profit (Loss) for the Period
24.62%
Total assets
14.55%
Total equity
8.02%
Operating Profit Margin (ROS)
2.1%
Net Profit Margin
1.69%
Return on Equity (ROE)
0.99%
Quick Ratio
-0.19%
Cash Ratio
-0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?